File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Prognostic role of molecular subclassification based on mutational profiling and tumor-associated neutrophil status in stage III colon cancer

TitlePrognostic role of molecular subclassification based on mutational profiling and tumor-associated neutrophil status in stage III colon cancer
Authors
Issue Date2022
PublisherAmerican Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/
Citation
Proceedings of the American Association for Cancer Research (AACR) 113th Annual Meeting, New Orleans, USA, 8-13 April,2022. In Cancer Research, 2022, v. 82 n. 12, Suppl., abstract 5266 How to Cite?
AbstractThe traditional prognostic prediction of colon cancer (CC) is based on the tumor-node-metastasis (TNM) system. This, however, is not adequate for clinical decision making due to the existence of inter-patient variations and heterogeneity of underlying molecular pathways. We aim to investigate the prognostic value of molecular subclassification utilizing i) tumor-associated neutrophil (TAN) status by immunohistochemical (IHC) staining; ii) microsatellite instability (MSI) and elevated microsatellite alteration at selected tetranucleotide repeats (EMAST) status by PCR-based microsatellite typing; and iii) next-generation sequencing (NGS) mutational profiling by deep sequencing of a 77-gene oncology panel. In the discovery phase, 130 pairs of archived normal and tumor formalin-fixed paraffin-embedded (FFPE) specimens of stage III CC patients were retrospectively recruited from Queen Mary Hospital. CC patients will be categorized into different molecular subclasses (MSCs) based on the status of TAN/MSI/EMAST/NGS mutational profiling molecular biomarkers. Kaplan-Meier analysis, log rank test, univariate and multivariate Cox proportional hazards regression analysis will be used for estimation of progression-free survival (PFS) and overall survival (OS) between the two groups of CC patients. We expect our data to provide useful information for improved stratification of stage III CC patients into high or low risk of recurrence and survival.
DescriptionE-Poster - Session OPO.CL01.01 - Translational Research - abstract no. 5266
Persistent Identifierhttp://hdl.handle.net/10722/313388
ISSN
2023 Impact Factor: 12.5
2023 SCImago Journal Rankings: 3.468

 

DC FieldValueLanguage
dc.contributor.authorCHAN, CY-
dc.contributor.authorLo, AWI-
dc.contributor.authorLam, KO-
dc.contributor.authorNg, HY-
dc.contributor.authorChen, CC-
dc.contributor.authorLung, ML-
dc.contributor.authorKo, JMY-
dc.date.accessioned2022-06-17T06:45:39Z-
dc.date.available2022-06-17T06:45:39Z-
dc.date.issued2022-
dc.identifier.citationProceedings of the American Association for Cancer Research (AACR) 113th Annual Meeting, New Orleans, USA, 8-13 April,2022. In Cancer Research, 2022, v. 82 n. 12, Suppl., abstract 5266-
dc.identifier.issn0008-5472-
dc.identifier.urihttp://hdl.handle.net/10722/313388-
dc.descriptionE-Poster - Session OPO.CL01.01 - Translational Research - abstract no. 5266-
dc.description.abstractThe traditional prognostic prediction of colon cancer (CC) is based on the tumor-node-metastasis (TNM) system. This, however, is not adequate for clinical decision making due to the existence of inter-patient variations and heterogeneity of underlying molecular pathways. We aim to investigate the prognostic value of molecular subclassification utilizing i) tumor-associated neutrophil (TAN) status by immunohistochemical (IHC) staining; ii) microsatellite instability (MSI) and elevated microsatellite alteration at selected tetranucleotide repeats (EMAST) status by PCR-based microsatellite typing; and iii) next-generation sequencing (NGS) mutational profiling by deep sequencing of a 77-gene oncology panel. In the discovery phase, 130 pairs of archived normal and tumor formalin-fixed paraffin-embedded (FFPE) specimens of stage III CC patients were retrospectively recruited from Queen Mary Hospital. CC patients will be categorized into different molecular subclasses (MSCs) based on the status of TAN/MSI/EMAST/NGS mutational profiling molecular biomarkers. Kaplan-Meier analysis, log rank test, univariate and multivariate Cox proportional hazards regression analysis will be used for estimation of progression-free survival (PFS) and overall survival (OS) between the two groups of CC patients. We expect our data to provide useful information for improved stratification of stage III CC patients into high or low risk of recurrence and survival.-
dc.languageeng-
dc.publisherAmerican Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/-
dc.relation.ispartofCancer Research-
dc.relation.ispartofAmerican Association for Cancer Research (AACR) Annual Meeting-
dc.titlePrognostic role of molecular subclassification based on mutational profiling and tumor-associated neutrophil status in stage III colon cancer-
dc.typeConference_Paper-
dc.identifier.emailNg, HY: hyng0812@hku.hk-
dc.identifier.emailLung, ML: mlilung@hku.hk-
dc.identifier.emailKo, JMY: joko@hku.hk-
dc.identifier.authorityLam, KO=rp01501-
dc.identifier.authorityLung, ML=rp00300-
dc.identifier.authorityKo, JMY=rp02011-
dc.description.natureabstract-
dc.identifier.doi10.1158/1538-7445.AM2022-5266-
dc.identifier.hkuros333591-
dc.identifier.volume82-
dc.identifier.issue12, Suppl.-
dc.identifier.spageabstract 5266-
dc.identifier.epageabstract 5266-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats